FMEDvsGNMXETF Comparison
VS
Fidelity Disruptive Medicine ETF (FMED) belongs to the Multiple Trends segment. Corgi Genomics & Precision Medicine ETF (GNMX) is part of the BioTech & Genomics segment. Both ETFs have the same top 1 sector exposures: Healthcare. FMED is more expensive with a Total Expense Ratio (TER) of 0.5%, versus 0.35% for GNMX. Run a side-by-side ETF comparison of FMED and GNMX below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
FMED vs GNMX performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 11/05/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | FMED GNMX | -4.35%-9.06% | +7.81%+16.01% | +14.76%n/a | +19.85%n/a | +48.91%n/a | n/an/a |
| Flows | FMED GNMX | -$3M-$1M | -$3M-$713K | -$20M- | -$18M- | -$15M- | -- |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | FMED GNMX | +31.58%+43.23% | +24.11%n/a | +20.23%n/a | n/an/a |
| Max drawdown | FMED GNMX | -7.63%-10.54% | -17.78%n/a | -19.20%n/a | n/an/a |
| Max drawdown duration | FMED GNMX | 69d8d | 212dn/a | 267dn/a | n/an/a |
Trading data
FMED | GNMX | |
Last sale | ||
| Previous close 11/04/2026 | ||
| Consolidated volume 11/04/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
FMED | GNMX | |
|---|---|---|
| Last price | – | – |
| 1D performance | – | – |
| AuM | $47.38 M | $1.25 M |
| E/R | 0.5% | 0.35% |
Characteristics
FMED | GNMX | |
|---|---|---|
| Management strategy | Active | Active |
| Provider | Fidelity | Corgi Funds |
| Benchmark | - | - |
| N° of holdings | 71 | 57 |
| Asset class | - | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 12, 2023 | May 6, 2026 |
| ESG | No | No |
Advertisement
Exposure
Countries
FMED
USA
84.97%
Other
15.03%
GNMX
USA
89.88%
Other
10.12%
Sectors
FMED
Healthcare
99.49%
Other
0.51%
GNMX
Healthcare
97.49%
Other
2.51%
Advertisement
Diversification
FMED
Total weight of top 15 holdings out of 15
47.18%
GNMX
Total weight of top 15 holdings out of 15
59.18%
Top 15 holdings
Data as of September 30, 2026
FMED
10X Genomics, Inc.
5.82%
Natera, Inc.
4.47%
Thermo Fisher Scientific, Inc.
4.19%
Danaher Corp.
3.92%
Illumina, Inc.
3.56%
argenx SE
2.96%
Lifestance Health Group, Inc.
2.87%
Revolution Medicines, Inc.
2.86%
Sartorius Stedim Biotech SA
2.72%
Moderna, Inc.
2.62%
Alnylam Pharmaceuticals, Inc.
2.48%
HeartFlow, Inc.
2.39%
Intuitive Surgical, Inc.
2.20%
Cogent Biosciences, Inc.
2.13%
Caris Life Sciences, Inc.
1.99%
GNMX
Moderna, Inc.
9.96%
Thermo Fisher Scientific, Inc.
8.42%
Vertex Pharmaceuticals, Inc.
5.71%
Illumina, Inc.
4.90%
Guardant Health, Inc.
3.48%
10X Genomics, Inc.
3.48%
Iovance Biotherapeutics, Inc.
3.17%
Revolution Medicines, Inc.
3.14%
Genmab A/S
3.00%
Twist Bioscience Corp.
2.64%
Incyte Corp.
2.53%
Alnylam Pharmaceuticals, Inc.
2.48%
GRAIL, Inc.
2.25%
Bio-Techne Corp.
2.13%
QIAGEN NV
1.89%
Frequently asked questions about FMED and GNMX
Which ETF is bigger: FMED or GNMX?
As of November 5, 2026, FMED holds $47.38 M in assets under management (AUM), while GNMX manages $1.25 M.
What sectors do the FMED and GNMX ETFs invest in?
FMED leans toward sectors like Healthcare. Meanwhile, GNMX focuses on Healthcare.
What are the top holdings of the FMED ETF and GNMX ETF?
FMED top holdings include 10X Genomics, Inc., Natera, Inc. and Thermo Fisher Scientific, Inc.. GNMX holds in its top three: Moderna, Inc., Thermo Fisher Scientific, Inc. and Vertex Pharmaceuticals, Inc..
Which ETF is more diversified: FMED or GNMX?
FMED holds 71 securities with 47.18% of its assets in the top 15. GNMX has 57 securities and a top 15 weight of 59.18%.
Advertisement
Advertisement
